Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping

Abstract Background This study aimed to synthetize the evidence on the effectiveness of harm minimization interventions on reducing blood-borne infection transmission and injecting behaviors among people who inject drugs (PWID) through a comprehensive overview of systematic reviews and evidence gap...

Full description

Bibliographic Details
Main Authors: Fernanda S. Tonin, Filipa Alves da Costa, Fernando Fernandez-Llimos
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Addiction Science & Clinical Practice
Subjects:
Online Access:https://doi.org/10.1186/s13722-024-00439-9
_version_ 1827326579776159744
author Fernanda S. Tonin
Filipa Alves da Costa
Fernando Fernandez-Llimos
author_facet Fernanda S. Tonin
Filipa Alves da Costa
Fernando Fernandez-Llimos
author_sort Fernanda S. Tonin
collection DOAJ
description Abstract Background This study aimed to synthetize the evidence on the effectiveness of harm minimization interventions on reducing blood-borne infection transmission and injecting behaviors among people who inject drugs (PWID) through a comprehensive overview of systematic reviews and evidence gap mapping. Methods A systematic review was conducted with searches in PubMed and Scopus to identify systematic reviews assessing the impact of interventions aimed at reducing the harms associated with injectable drug use. The overall characteristics of the studies were extracted and their methodological quality was assessed using AMSTAR-2. An evidence gap map was constructed, highlighting the most frequently reported outcomes by intervention (CRD42023387713). Results Thirty-three systematic reviews were included. Of these, 14 (42.2%) assessed the impact of needle/syringe exchange programs (NSEP) and 11 (33.3%) examined opioid agonist therapy (OAT). These interventions are likely to be associated with reductions of HIV/HCV incidence (10–40% risk reduction for NSEP; 50–60% for OAT) and sharing injecting paraphernalia (50% for NSEP, 25–85% for OAT), particularly when combined (moderate evidence). Behavioral/educational interventions were assessed in 12 reviews (36.4%) with most authors in favor/partially in favor of the use of these approaches (moderate evidence). Take-home naloxone programs and supervised-injection facilities were each assessed in two studies (6.1%), which reported inconclusive results (limited/inconsistent evidence). Most authors reported high levels of heterogeneity and risk of bias. Other interventions and outcomes were inadequately reported. Most systematic reviews presented low or critically low quality. Conclusion The evidence is sufficient to support the effectiveness of OAT, NSEP and their combination in reducing blood-borne infection transmission and certain injecting behaviors among PWID. However, evidence of other harm minimizations interventions in different settings and for some outcomes remain insufficient.
first_indexed 2024-03-07T14:47:37Z
format Article
id doaj.art-65ab9b4eccff4749ba251140f3d6e402
institution Directory Open Access Journal
issn 1940-0640
language English
last_indexed 2024-03-07T14:47:37Z
publishDate 2024-02-01
publisher BMC
record_format Article
series Addiction Science & Clinical Practice
spelling doaj.art-65ab9b4eccff4749ba251140f3d6e4022024-03-05T19:53:11ZengBMCAddiction Science & Clinical Practice1940-06402024-02-0119112210.1186/s13722-024-00439-9Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mappingFernanda S. Tonin0Filipa Alves da Costa1Fernando Fernandez-Llimos2H&TRC - Health & Technology Research Center, ESTeSL - Escola Superior de Tecnologia da Saúde, Instituto Politécnico de LisboaResearch Institute for Medicines (iMED.ULisboa), Faculty of Pharmacy, University of LisbonApplied Molecular Biosciences Unit, (UCIBIO-i4HB) Laboratory of Pharmacology, Faculty of Pharmacy, University of PortoAbstract Background This study aimed to synthetize the evidence on the effectiveness of harm minimization interventions on reducing blood-borne infection transmission and injecting behaviors among people who inject drugs (PWID) through a comprehensive overview of systematic reviews and evidence gap mapping. Methods A systematic review was conducted with searches in PubMed and Scopus to identify systematic reviews assessing the impact of interventions aimed at reducing the harms associated with injectable drug use. The overall characteristics of the studies were extracted and their methodological quality was assessed using AMSTAR-2. An evidence gap map was constructed, highlighting the most frequently reported outcomes by intervention (CRD42023387713). Results Thirty-three systematic reviews were included. Of these, 14 (42.2%) assessed the impact of needle/syringe exchange programs (NSEP) and 11 (33.3%) examined opioid agonist therapy (OAT). These interventions are likely to be associated with reductions of HIV/HCV incidence (10–40% risk reduction for NSEP; 50–60% for OAT) and sharing injecting paraphernalia (50% for NSEP, 25–85% for OAT), particularly when combined (moderate evidence). Behavioral/educational interventions were assessed in 12 reviews (36.4%) with most authors in favor/partially in favor of the use of these approaches (moderate evidence). Take-home naloxone programs and supervised-injection facilities were each assessed in two studies (6.1%), which reported inconclusive results (limited/inconsistent evidence). Most authors reported high levels of heterogeneity and risk of bias. Other interventions and outcomes were inadequately reported. Most systematic reviews presented low or critically low quality. Conclusion The evidence is sufficient to support the effectiveness of OAT, NSEP and their combination in reducing blood-borne infection transmission and certain injecting behaviors among PWID. However, evidence of other harm minimizations interventions in different settings and for some outcomes remain insufficient.https://doi.org/10.1186/s13722-024-00439-9Harm reductionInjectable drug useBlood-borne infectionsSystematic reviewsEvidence gaps
spellingShingle Fernanda S. Tonin
Filipa Alves da Costa
Fernando Fernandez-Llimos
Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
Addiction Science & Clinical Practice
Harm reduction
Injectable drug use
Blood-borne infections
Systematic reviews
Evidence gaps
title Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
title_full Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
title_fullStr Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
title_full_unstemmed Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
title_short Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
title_sort impact of harm minimization interventions on reducing blood borne infection transmission and some injecting behaviors among people who inject drugs an overview and evidence gap mapping
topic Harm reduction
Injectable drug use
Blood-borne infections
Systematic reviews
Evidence gaps
url https://doi.org/10.1186/s13722-024-00439-9
work_keys_str_mv AT fernandastonin impactofharmminimizationinterventionsonreducingbloodborneinfectiontransmissionandsomeinjectingbehaviorsamongpeoplewhoinjectdrugsanoverviewandevidencegapmapping
AT filipaalvesdacosta impactofharmminimizationinterventionsonreducingbloodborneinfectiontransmissionandsomeinjectingbehaviorsamongpeoplewhoinjectdrugsanoverviewandevidencegapmapping
AT fernandofernandezllimos impactofharmminimizationinterventionsonreducingbloodborneinfectiontransmissionandsomeinjectingbehaviorsamongpeoplewhoinjectdrugsanoverviewandevidencegapmapping